Screening for cancer with PET and PET/CT: potential and limitations.
about
Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screeningPET/CT in paediatric malignancies - An updateNon-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and bNear-infrared spectral tomography integrated with digital breast tomosynthesis: effects of tissue scattering on optical data acquisition design.Combined optical and X-ray tomosynthesis breast imagingThe current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide surveyGenetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker.EPMA position paper in cancer: current overview and future perspectives.A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.Targeting breast cancer with sugar-coated carbon nanotubes.FLT-PET imaging of radiation responses in murine tumorsPositron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PETOptical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.[(18)F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysis.Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesionsRole and cost effectiveness of PET/CT in management of patients with cancer.Hyperpolarized Sodium [1-13C]-Glycerate as a Probe for Assessing Glycolysis In Vivo.Molecular imaging biomarkers for cell-based immunotherapies.Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor modelLung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role.Application of whole-body FDG-PET for cancer screening in a cohort of hospital employees.Improved short tau inversion recovery (iSTIR) for increased tumor conspicuity in the abdomen.Use of confocal laser endomicroscopy with a fluorescently labeled fatty acid to diagnose colorectal neoplasms.ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study.Whole-body MRI for metastatic cancer detection using T2 -weighted imaging with fat and fluid suppression.
P2860
Q26995072-1C06F136-F029-4875-AB37-671AE4781725Q28066175-139A152E-7B14-4DA2-924B-63989829D9D0Q33743741-2DA55502-F232-40AC-84E5-99E64786C090Q33823389-65A10008-D72E-4BFD-A5B9-13B9B1A31166Q34351444-558EB93D-BCEC-44FE-9FAF-FC71907EBCB7Q34436402-2B762A7D-13FA-4523-AD0A-53107EDA96C2Q35083610-CC9D98A9-3185-420B-B91E-07170A7E763BQ35329596-0108DD47-0F80-4007-99EA-ACDE84620AFFQ35532215-F36540C0-C591-457D-A69A-2E658818A4FCQ35752017-23ABE5FA-962D-4943-847C-08B5BF599A72Q36175013-00C63EB4-6287-4708-8F7D-5FE6254E56CAQ37227814-99937C66-FCC2-43FE-9A03-4E3A67A3A07EQ37242516-F22626F1-838A-427C-A22F-77DD8FE51EA6Q37274516-EB4B7640-A666-408A-B32D-B73819472223Q37394789-146B35CD-C17C-43E8-A68A-E9CA46F6B74BQ37511930-A723136F-488A-4A8E-ADE7-1E351F9E7717Q37768682-16D59E1A-7028-4545-A358-DEF67FE97B49Q38688183-79B3A8F0-52C0-4929-9407-9A29A30D6E32Q39383670-498D727E-B7AA-487E-9C56-1E84B215E138Q39834174-FAC44999-3E7E-4333-A708-F0A3CCC28F7AQ40730325-D46FD6EF-D5B9-4E2C-A18B-A2B142358778Q41485060-C1B51097-4FEC-47F5-B888-FFAFF9B0A8E7Q41614765-8A52F431-850C-4936-9761-1BC006E45FDAQ41708873-1A1EBEE4-5DF3-4B1B-AFC0-15DAF40B9787Q46198687-7D33D403-3A9C-47CE-A566-D131F26FC321Q47163996-F967AF39-D3F9-45EE-8C05-FB3966331594Q49990418-D53D68E3-C151-4548-9B8E-FD743FBA5348
P2860
Screening for cancer with PET and PET/CT: potential and limitations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Screening for cancer with PET and PET/CT: potential and limitations.
@ast
Screening for cancer with PET and PET/CT: potential and limitations.
@en
type
label
Screening for cancer with PET and PET/CT: potential and limitations.
@ast
Screening for cancer with PET and PET/CT: potential and limitations.
@en
prefLabel
Screening for cancer with PET and PET/CT: potential and limitations.
@ast
Screening for cancer with PET and PET/CT: potential and limitations.
@en
P1476
Screening for cancer with PET and PET/CT: potential and limitations
@en
P2093
Heiko Schöder
Mithat Gönen
P304
P407
P478
48 Suppl 1
P50
P577
2007-01-01T00:00:00Z